Skip to content
Search

Latest Stories

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

She will rejoin the organisation after six years to head one of the country's largest NHS Trusts.

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard, who is set to step down as NHS England chief in April, has been appointed as the next chief executive of Guy’s and St Thomas’ NHS Foundation Trust.

Pritchard previously led the Trust from October 2015 to August 2019 before moving to NHS England, where she later became its first female chief executive in August 2021.


The Trust confirmed her appointment on Monday (17 March) following a competitive recruitment process and approval by the Council of Governors.

She will succeed Professor Ian Abbs, who announced in January that he will stand down in 2025.

Returning to an expanded organisation following its merger with Royal Brompton and Harefield Hospitals in 2021, Pritchard will lead one of the largest NHS Trusts in the country.

Charles Alexander, chairman of Guy’s and St Thomas’, praised Pritchard’s outstanding vision for the Trust.

He said: "We were extremely impressed by Amanda’s enthusiasm, energy and commitment to the future success of Guy’s and St Thomas’.

“She will return to a very different organisation from the one that she left 6 years ago and clearly demonstrated her vision and support for our ambitious plans, combined with the need to lead transformational change at pace.”

“We and our local healthcare and academic partners are fortunate that we will be able to benefit from the significant experience that Amanda has acquired during her time at NHS England as she returns to a role in frontline healthcare delivery.”

Expressing her pride in rejoining the Trust, Pritchard acknowledged the changes since her departure in 2019.

“It is an honour to be appointed to the role of Chief Executive at Guy’s and St Thomas’ – the organisation is now very different to the one I left in 2019 and I am delighted and proud to return to lead it,” she said.

“Guy’s and St Thomas’ is one of the country’s leading providers and I am very much looking forward to connecting with colleagues old and new as, together, we work to improve and transform the experiences of our staff and patients,” she added.

Pritchard first joined Guy’s and St Thomas’ as chief operating officer in 2012. Before that, she held several senior positions at Chelsea and Westminster NHS Foundation Trust and worked in the Prime Minister’s Delivery Unit.


More For You

More patients on weight-loss injections undergoing gallbladder removal, warns pharmacist

Weight-loss injections can make bile more sludgy and even lead to the formation of gallstones

GettyImages

Weight-loss injections can cause gallstones, warns pharmacist

A leading pharmacist has raised concerns over a rise in gallbladder issues among individuals using weight-loss injections, particularly Eli Lilly’s Mounjaro (tirzepatide).

Deborah Grayson, a pharmacist and nutritional therapist, shared an alert in a TikTok video, highlighting the potential effects of weight-loss injections on gallbladder health.

Keep ReadingShow less
 Gordons Chemists sells Scottish pharmacies to focus on home market

Gordons Chemist in Helensburgh

Image credit: Christie & Co

Gordons Chemists exits Scottish market to focus on Northern Ireland network

Gordons Chemists, Northern Ireland’s largest independent pharmacy chain, has sold all nine of its Scottish pharmacies as part of a strategic decision to refocus on its home market.

Broker Christie & Co recently announced the sale of the pharmacies, located in Helensburgh, Alexandria, Milngavie, Cowdenbeath, Musselburgh, Edinburgh, Armadale, Stranraer, and Oban.

Keep ReadingShow less
ABPI criticises proposed chances to payment rate for newer branded medicines

DHSC launches an open consultation seeking feedback on the proposed changes to the Statutory Scheme payment rate

Getty Images

Rising payment rate for branded medicines exposes ‘fundamentally broken’ UK market – ABPI

The Association of the British Pharmaceutical Industry (ABPI) has criticised the government’s proposed changes to the Statutory Scheme payment rate for newer branded medicines, warning that it reflects a “fundamentally broken” UK medicines market.

The ‘payment rate’ refers to the amount of revenue pharmaceutical companies must return to the government on their sales of branded medicines to the NHS—an additional charge on top of standard taxes.

Keep ReadingShow less
NHS staff facing rising violence and record discrimination, survey reveals

1 in 7 NHS staff experienced physical violence from patients, their relatives or the public in 2024

Getty Images

Attacks on NHS staff surge, discrimination at highest levels - survey finds

Workplace discrimination has reached its highest level in five years, with 9.25% of staff reporting experiences of discrimination, according to the latest annual NHS staff survey.

More than half (54.09%) of those affected said the discrimination they received from patients and the public was based on their ethnic background.

Keep ReadingShow less
Man jailed for robbing pharmacy at knifepoint

Daniel Bennett threatened to harm staff unless medication was handed over.

Man jailed for robbing pharmacy at knifepoint

A man who robbed a pharmacy in Winterbourne last year at knifepoint has been sentenced to prison.

Daniel Bennett, 41 of Wedmore Vale in Bedminster, was jailed for six years and nine months, with an extended three-year licence period, after pleading guilty to robbery and possession of a bladed article.

Keep ReadingShow less